Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)

Journal of the American Medical Association

Volumn 285, Issue 19, 2001, Pages 2486-2497

  Cleeman, J I ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CERIVASTATIN; CHOLESTEROL; CLOFIBRATE; COLESTIPOL; COLESTYRAMINE; FENOFIBRATE; FIBRIC ACID DERIVATIVE; FLUINDOSTATIN; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; NICOTINIC ACID DERIVATIVE; PRAVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; DIET; FEMALE; GALLSTONE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERURICEMIA; LIFESTYLE; LIPOPROTEIN METABOLISM; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MYOPATHY; PHYSICAL ACTIVITY; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; WEIGHT REDUCTION;

EID: 0035897696     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.19.2486     Document Type: Article

References (0)